Get the Stockscreener App
3.75
8.38%
0.29
After Hours:
3.88
0.13
+3.47%
Endra Life Sciences Inc stock is traded at $3.75, with a volume of 221.10K.
It is up +8.38% in the last 24 hours and down -1.57% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$3.46
Open:
$3.3
24h Volume:
221.10K
Relative Volume:
2.17
Market Cap:
$4.37M
Revenue:
-
Net Income/Loss:
$-8.01M
P/E Ratio:
-0.28
EPS:
-13.3923
Net Cash Flow:
$-5.10M
1W Performance:
+9.97%
1M Performance:
-1.57%
6M Performance:
-23.47%
1Y Performance:
-12.79%
1-Day Range:
$3.22
$3.90
1-Week Range:
$3.1907
$3.90
52-Week Range:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
3.75 | 4.04M | 0 | -8.01M | -5.10M | -13.39 |
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Endra Life Sciences Inc Stock (NDRA) Latest News
Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside - FinancialContent
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value - BioSpace
ENDRA Life Sciences Explores Strategic Alternatives Amid Restructuring - TipRanks
Strategic options review launched by ENDRA Life Sciences (Nasdaq: NDRA) - Stock Titan
ENDRA Life Sciences explores strategic alternatives - Investing.com
ENDRA (NDRA) Explores Strategic Options to Enhance Shareholder V - GuruFocus
ENDRA Life Sciences Inc announced that its Board of Directors has initiated a strategic review process aimed at a comprehensive assessment of the company’s future development pathways. - Bitget
ENDRA Life Sciences (NDRA) Expected to Announce Quarterly Earnings on Monday - Defense World
If You Invested $1,000 in Endra Life Sciences Inc (NDRA) - Stock Titan
Tech Rally: Is ENDRA Life Sciences Inc being accumulated by smart money2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - The Chronicle-Journal
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
ENDRA Life Sciences (NASDAQ: NDRA) - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom - openPR.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
User - The Chronicle-Journal
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now! - Barchart.com
FinancialContentFavorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - FinancialContent
Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA - FinancialContent
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - Barchart
Favorable Results on Liver Device for Long-Term Monitoring - openPR.com
Will ENDRA Life Sciences Inc. stock outperform growth indexesWeekly Trend Summary & Reliable Entry Point Alerts - Naître et grandir
[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity - Stock Titan
ENDRA Life Sciences (NDRA) CFO awarded 13,461 restricted stock units - Stock Titan
NDRA's TAEUS system Reaches MRI-Comparable Accuracy in Liver Imaging - Bitget
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision - TradingView
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Large Growth in Short Interest - Defense World
NDRA Should I Buy - Intellectia AI
NDRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Le - PharmiWeb.com
Endra Life Sciences (NDRA) Announces Positive Trial Results for Liver Device - GuruFocus
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care - Yahoo Finance
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now! - openPR.com
Sell Signal: What are the future prospects of ENDRA Life Sciences Inc2025 Market Trends & Verified Momentum Stock Alerts - baoquankhu1.vn
Does ENDRA Life Sciences Inc. outperform in volatile marketsJuly 2025 Reactions & Weekly Top Stock Performers List - mfd.ru
Can Enviri Corporation reach all time highs this yearWeekly Risk Report & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Update Report: Whats the MACD signal for ENDRA Life Sciences IncJuly 2025 Catalysts & Consistent Profit Trade Alerts - baoquankhu1.vn
ENDRA Life Sciences (NASDAQ: NDRA): A Dual-Engine Growth Story - openPR.com
Can ENDRA Life Sciences Inc. reach all time highs this yearJuly 2025 EndofMonth & Expert Curated Trade Setup Alerts - mfd.ru
Can ENDRA Life Sciences Inc. stock sustain free cash flow growth2025 Historical Comparison & Daily Profit Maximizing Trade Tips - mfd.ru
Resistance Check: What is the target price for ENDRA Life Sciences Inc stock2025 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Technical Analysis: Is ENDRA Life Sciences Inc being accumulated by smart moneyWeekly Stock Summary & Verified Short-Term Trading Plans - baoquankhu1.vn
Street Watch: Whats the MACD signal for ENDRA Life Sciences IncWeekly Investment Summary & Long-Term Safe Investment Ideas - baoquankhu1.vn
ENDRA Life Sciences (NASDAQ: NDRA) Gaining Attention as HYPE Token Surges See Why Now! FEED, SER, TRX, XHLD, BATL Inside - Barchart.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Smart Money: What is the PEG ratio of ENDRA Life Sciences Inc2025 Major Catalysts & Long-Term Growth Plans - baoquankhu1.vn
$5 Stocks: NDRA, IBRX, MOVE, RVLY Drawing Attention Watch Now! - openPR.com
MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRAJanuary 2026 Focus - openPR.com
MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRA – January 2026 Focus - Barchart.com
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):